Company


nature
-1.68%





Base:2,622

opening:2,578

Tall:0

low:0

change:

Page Quote News Graphs Company Profile Recommendations


More articles on the subject:




She was left alone in the opioid case in New York: All the drug companies against them filed lawsuits for the sale of painkillers that cause addiction and reached an agreement with the authorities except for Teva.

Now the Allergen Group has also reached an agreement with the New York authorities, according to which it will pay $ 200 million because it aggressively marketed powerful painkillers that led to severe addiction of non-terminally ill patients, in what various sources claim led to the addiction and death of more than half a million people.

Allergen will pay the compensation by 2022, it was further stated that the money it will transfer will be allocated to the treatment of drug addicts, and the victims of the “opioid epidemic”. The New York Attorney General said: “No amount of money can compensate for the death or addiction of thousands of people in the state to painkillers, but the money we receive will be used to prevent future destruction.”

Allergen’s compromise leaves Teva alone in the legal process in New York State. However, Teva has reached a point compromise in a number of claims in other countries and it may reach compromises in all claims – it will be difficult, it will be long, it will cost a lot of money, but it will probably keep the company alive.

Last September, Teva also reached a settlement with the state attorney general of the state of Louisiana, which settles the state’s lawsuits dealing with opioids. The agreement is subject to final approval by the state on November 1st. Under the agreement all the counties in the state release Teva from the claims as part of the arrangement.

Comments on the article(0):

Your response has been received and will be published subject to system policies.
Thanks.

For a new response

Your response was not sent due to a communication problem, please try again.

Return to comment

.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.